Dossier
SARS-CoV-2 Omicron variant
Coverage of SARS-CoV-2 Omicron variant in the Nexus archive.
- Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
The article is an author correction published in Nature regarding the reduced fusogenicity and pathogenicity of the SARS-CoV-2 Omicron variant. It updates or clarifies findings from a prior study on the variant's characteristics.
- Steric hindrance of antibody binding in an Omicron spike fusion intermediate
The SARS-CoV-2 Omicron variant escapes neutralization by antibodies due to steric hindrance, but reducing antibody size can overcome this barrier. This allows for a broader range of accessible targets. The study was published in Nature on May 6, 2026.